NHL..com: What is the next time frame?
– Time.com (October 1, 2018)Time.com, the online newspaper of the NHL, is reporting that, in 2019, the NHL will begin testing a new drug, called TIM, in an effort to speed up the healing process.
The drug, which has been in the works for years, is designed to help speed up recovery from trauma, particularly a traumatic brain injury (TBI) or concussion.
TIM will be administered via a nasal spray.
Tim Norman, a doctor and orthopedic surgeon in Colorado, told Time.
Tim Normans initial findings in a study are promising, according to the Times.
In his studies, Normans team of researchers found that the drug could reduce the pain associated with TBI or concussion, reduce swelling, improve sleep and reduce the symptoms of the disease.
Normans group also found that TIM can improve cognitive function in the patients.
According to the report, the drug has been approved by the Food and Drug Administration and is currently in clinical trials in England.
Tim’s research has also shown it could speed up healing after head injuries in both healthy and injured athletes.
Tim said in a news release: The results of our Phase 1 clinical trials have indicated that TIM improves the cognitive recovery and quality of life in a number of athletes who sustained a TBI.
TIM is a safe, effective and cost-effective intervention to slow and stop the progression of TBI in athletes.
Tim and his team also have an ongoing Phase 2 trial in the U.K. and are working to expand it.
Tim says that Tim is the first to use TIM in a clinical setting.
What do you think of Tim’s research findings?
Will TIM have a positive effect on athletes?
Share your thoughts below.
Tim was able to prove the drug’s efficacy in patients with traumatic brain injuries.
Tim Normans findings in Phase 1 and Phase 2 of TIM research are promising.
Tim will be giving a presentation at the American College of Sports Medicine Annual Conference in April.
Source: NHL.tv | Time.org